Showing results (91-100 of 518) with videos related to
Sort By:
Pageof 52
Genome Medicine|November 1, 2018
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back againSamantha L Bucktrout, Jeffrey A Bluestone, Fred RamsdellAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2003
Clinical trials of transplant tolerance: slow but steady progressJeffrey B Matthews, Eleanor Ramos, Jeffrey A BluestoneThe Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J MadrenasThe Journal of Experimental Medicine|April 1, 1986
Cloned cytotoxic T lymphocytes that recognize an I-A region product in the context of a class I antigenN Shinohara, J A Bluestone, D H SachsSeminars in Immunology|February 7, 2006
Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potentialEmma L Masteller, Qizhi Tang, Jeffrey A BluestoneJournal of Clinical Immunology|August 22, 2008
T regulatory cells in autoimmune diabetes: past challenges, future prospectsJeffrey A Bluestone, Qizhi Tang, Caitlin E SedwickThe Journal of Experimental Medicine|January 8, 2003
Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4Shunsuke Chikuma, John B Imboden, Jeffrey A BluestoneThe Journal of Allergy and Clinical Immunology|July 12, 2002
The immune tolerance network: a new paradigm for developing tolerance-inducing therapiesDaniel Rotrosen, Jeff B Matthews, Jeffrey A BluestoneThe Journal of Nutrition|August 2, 2001
Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosisM Kaplan, T Hayek, A Raz, et al.Immunologic Research|February 1, 1997
CD28/B7 regulation of autoimmune diabetesK G Herold, D J Lenschow, J A BluestonePageof 52